Rabies vaccine im
Products billed under this code include Imovax Rabies, Rabavert.
Payment limit per 1 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Imovax Rabies, Rabavert.
Payment limit per 1 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Imovax Rabies | Sanofi Pasteur Inc. | 49281-0252-51 | 1 | $327.987 |
| Rabavert | Bavarian Nordic Inc. | 50632-0010-01 | 1 | $327.987 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $327.987 | −$3.99 | 1 ML | Rabies vaccine im | v1, posted September 17, 2026 |
| 3Q26 | $331.977 | +$16.758 | 1 ML | Rabies vaccine im | v1, posted September 15, 2026 |
| 2Q26 | $315.219 | −$4.529 | 1 ML | Rabies vaccine im | v1, posted September 15, 2026 |
| 1Q26 | $319.748 | +$6.069 | 1 ML | Rabies vaccine im | v1, posted September 15, 2026 |
| 4Q25 | $313.679 | +$1.649 | 1 ML | Rabies vaccine im | v1, posted September 8, 2026 |
| 3Q25 | $312.03 | −$5.643 | 1 ML | Rabies vaccine im | v1, posted March 10, 2026 |
| 2Q25 | $317.673 | −$10.103 | 1 ML | Rabies vaccine im | v1, posted March 10, 2026 |
| 1Q25 | $327.776 | −$22.364 | 1 ML | Rabies vaccine im | v1, posted December 19, 2025 |
| 4Q24 | $350.14 | +$11.647 | 1 ML | Rabies vaccine im | v1, posted June 11, 2025 |
| 3Q24 | $338.493 | +$15.728 | 1 ML | Rabies vaccine im | v1, posted June 11, 2025 |
| 2Q24 | $322.765 | −$1.979 | 1 ML | Rabies vaccine im | v1, posted March 11, 2025 |
| 1Q24 | $324.744 | −$3.805 | 1 ML | Rabies vaccine im | v1, posted December 19, 2024 |
| 4Q23 | $328.549 | −$1.44 | 1 ML | Rabies vaccine im | v1, posted October 10, 2024 |
| 3Q23 | $329.989 | −$12.235 | 1 ML | Rabies vaccine im | v1, posted June 5, 2024 |
| 2Q23 | $342.224 | −$12.993 | 1 ML | Rabies vaccine im | v1, posted February 23, 2024 |
| 1Q23 | $355.217 | +$6.69 | 1 ML | Rabies vaccine im | v1, posted December 6, 2023 |
| 4Q22 | $348.527 | +$56.736 | 1 ML | Rabies vaccine im | v1, posted June 22, 2023 |
| 3Q22 | $291.791 | −$1.797 | 1 ML | Rabies vaccine im | v1, posted June 9, 2023 |
| 2Q22 | $293.588 | −$48.358 | 1 ML | Rabies vaccine im | v1, posted December 14, 2022 |
| 1Q22 | $341.946 | +$14.414 | 1 ML | Rabies vaccine im | v1, posted June 8, 2022 |
| 4Q21 | $327.532 | +$0.918 | 1 ML | Rabies vaccine im | v1, posted June 2, 2022 |
| 3Q21 | $326.614 | −$20.562 | 1 ML | Rabies vaccine im | v1, posted June 2, 2022 |
| 2Q21 | $347.176 | +$29.12 | 1 ML | Rabies vaccine im | v1, posted March 1, 2022 |
| 1Q21 | $318.056 | – | 1 ML | Rabies vaccine im | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.